On September 1, 2022 ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, reported that management will participate in the following investor conferences in September (Press release, ORIC Pharmaceuticals, SEP 1, 2022, View Source [SID1234618883]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 17th Annual Biopharma Conference – Targeted oncology panel discussion on Thursday, September 8, 2022, at 2:40 p.m. ET

Wells Fargo Healthcare Conference – Participating in fireside chat on Friday, September 9, 2022, at 8:35 a.m. ET

H.C. Wainwright 24th Annual Global Investment Conference – Presenting company overview on Monday, September 12, 2022, at 7:00 a.m. ET
Webcasts of the panel discussion and presentations will be available through the investor section of the company’s website at www.oricpharma.com. Replays of webcasts will be available for 90 days following the events.